Pfizer Remains Immune To Lipitor Attack In U.K.
Chalking up another win for Pfizer Inc., a British appellate court has upheld the primary patent behind blockbuster cholesterol drug Lipitor, thwarting Ranbaxy Laboratories Ltd. yet again from launching a generic...To view the full article, register now.
Already a subscriber? Click here to view full article